Bird flu money triggers new look at antivirals

The surge of interest in bird flu research has caused a host of researchers to focus on new therapies for viral diseases. While many new programs are getting started to find treatments specifically for a potential outbreak of avian flu among humans, the sudden spotlight is forcing a broad review of therapies for all types of viral ailments. As long as more money flows into antivirals, look for researchers to regear accordingly.

- here's the report from the Boston Globe for more information

ALSO: Novavax has partnered with India's Bharat Biotech to develop a bird flu vaccine for south Asia. Release

PLUS: The rapid spread of the bird flu virus around the globe is stumping the experts. Article